Tazemetostat

TAZVERIK®

Overview

Tazmetostat is an EZH2 inhibitor that helps stop the spread of cancer cells.

SparkCures ID 449
Brand Name Tazverik®
Generic Name Tazemetostat
Treatment Classifications

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)

Resources

There are no resources, links or videos to display for this treatment.